- JP-listed companies
- TAKARA BIO INC.
- Dividends
TAKARA BIO INC.【JP:4974】Dividends
Market cap
¥138.1B
P/E ratio
-15.3x
Takara Bio develops and manufactures biotechnology products including research reagents, PCR instruments, and gene therapy treatments for universities, research institutions, and companies worldwide.
Latest Dividend per Share Forecast
17.00JPY
If you buy 100 shares of TAKARA BIO INC., the expected annual dividend is 1,700 JPY.
- Dividend Yield
- 1.5%
- Payout Ratio
- 157.5%
Dividend Policy
<p>Our basic policy is to strengthen internal reserves to actively pursue research and development activities, while implementing profit returns by comprehensively considering our operating results and financial position. Historically, we have targeted dividends at approximately 35% of estimated net income for the period, excluding extraordinary gains and losses. We pay dividends twice annually—interim dividends and year-end dividends—and allocate retained earnings to strengthen our financial position and fund research and development investments and capital expenditures.</p>
Dividend per Share
Payout Ratio
Dividend Yield
Dividend History (Forecasts, Revisions, Actuals)
| Fiscal Year | Type | Interim | Year-End | Total | Payout Ratio |
| FY2026 | Revision(2025/11/11) | 0 | 0 | 0 | - |
|---|---|---|---|---|---|
| Forecast(2025/05/13) | 0 | 17 | 17 | 157.5% | |
| FY2025 | Actual(2025/05/13) | 0 | 17 | 17 | 196.5% |
| Forecast(2024/05/10) | 0 | 17 | 17 | 60.2% | |
| FY2024 | Actual(2024/05/10) | 0 | 17 | 17 | 138.2% |
| Forecast(2023/05/11) | 0 | 17 | 17 | 37.2% | |
| FY2023 | Actual(2023/05/11) | 0 | 42 | 42 | 31.6% |
| Revision(2023/02/09) | 0 | 42 | 42 | - | |
| Revision(2022/11/10) | 0 | 40 | 40 | - | |
| Forecast(2022/05/12) | 0 | 33 | 33 | 37.5% | |
| FY2022 | Actual(2022/05/12) | 0 | 33 | 33 | 20.0% |
| Revision(2022/02/10) | 0 | 30 | 30 | - | |
| Revision(2021/11/09) | 0 | 24 | 24 | - | |
| Revision(2021/08/03) | 0 | 20 | 20 | - | |
| Forecast(2021/05/13) | 0 | 16 | 16 | 19.7% | |
| FY2021 | Actual(2021/05/13) | 0 | 16 | 16 | 20.2% |
| Revision(2021/02/10) | 0 | 14 | 14 | - | |
| Forecast(2020/11/10) | 0 | 9 | 9 | - | |
| FY2020 | Actual(2020/11/10) | 0 | 8 | 8 | - |